267 related articles for article (PubMed ID: 9617746)
1. Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?
Benzi G; Moretti A
Eur J Pharmacol; 1998 Apr; 346(1):1-13. PubMed ID: 9617746
[TBL] [Abstract][Full Text] [Related]
2. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J
Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease.
Imbimbo BP
CNS Drugs; 2001; 15(5):375-90. PubMed ID: 11475943
[TBL] [Abstract][Full Text] [Related]
4. Old and new acetylcholinesterase inhibitors for Alzheimer's disease.
Galimberti D; Scarpini E
Expert Opin Investig Drugs; 2016 Oct; 25(10):1181-7. PubMed ID: 27459153
[TBL] [Abstract][Full Text] [Related]
5. Does the application of acetylcholinesterase inhibitors in the treatment of Alzheimer's disease lead to depression?
Mitić M; Lazarević-Pašti T
Expert Opin Drug Metab Toxicol; 2021 Jul; 17(7):841-856. PubMed ID: 33999717
[No Abstract] [Full Text] [Related]
6. The role of acetylcholinesterase in the pathogenesis of Alzheimer's disease.
Rees TM; Brimijoin S
Drugs Today (Barc); 2003 Jan; 39(1):75-83. PubMed ID: 12669110
[TBL] [Abstract][Full Text] [Related]
7. Reimagining cholinergic therapy for Alzheimer's disease.
Giacobini E; Cuello AC; Fisher A
Brain; 2022 Jul; 145(7):2250-2275. PubMed ID: 35289363
[TBL] [Abstract][Full Text] [Related]
8. [Acetylcholinesterase inhibitors for treatment of Alzheimer's disease].
Shinagawa S; Shigeta M
Brain Nerve; 2014 May; 66(5):507-16. PubMed ID: 24807367
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic M(1) agonists in the treatment of Alzheimer's disease.
Korczyn AD
Expert Opin Investig Drugs; 2000 Oct; 9(10):2259-67. PubMed ID: 11060805
[TBL] [Abstract][Full Text] [Related]
10. Cholinergic drugs in pharmacotherapy of Alzheimer's disease.
Camps P; Muñoz-Torrero D
Mini Rev Med Chem; 2002 Feb; 2(1):11-25. PubMed ID: 12369954
[TBL] [Abstract][Full Text] [Related]
11. New pharmacological approaches to the cholinergic system: an overview on muscarinic receptor ligands and cholinesterase inhibitors.
Greig NH; Reale M; Tata AM
Recent Pat CNS Drug Discov; 2013 Aug; 8(2):123-41. PubMed ID: 23597304
[TBL] [Abstract][Full Text] [Related]
12. Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease.
Martinez A; Castro A
Expert Opin Investig Drugs; 2006 Jan; 15(1):1-12. PubMed ID: 16370929
[TBL] [Abstract][Full Text] [Related]
13. Modulators of Acetylcholinesterase Activity: From Alzheimer's Disease to Anti-Cancer Drugs.
Lazarevic-Pasti T; Leskovac A; Momic T; Petrovic S; Vasic V
Curr Med Chem; 2017; 24(30):3283-3309. PubMed ID: 28685687
[TBL] [Abstract][Full Text] [Related]
14. [Acetylcholinesterase inhibitors in Alzheimer's disease: further comments on their mechanisms of action and therapeutic consequences].
Nieoullon A
Psychol Neuropsychiatr Vieil; 2010 Jun; 8(2):123-31. PubMed ID: 20525543
[TBL] [Abstract][Full Text] [Related]
15. Multi-target design strategies in the context of Alzheimer's disease: acetylcholinesterase inhibition and NMDA receptor antagonism as the driving forces.
Rosini M; Simoni E; Minarini A; Melchiorre C
Neurochem Res; 2014 Oct; 39(10):1914-23. PubMed ID: 24493627
[TBL] [Abstract][Full Text] [Related]
16. Non-cholinergic effects of huperzine A: beyond inhibition of acetylcholinesterase.
Zhang HY; Yan H; Tang XC
Cell Mol Neurobiol; 2008 Feb; 28(2):173-83. PubMed ID: 17657601
[TBL] [Abstract][Full Text] [Related]
17. Cholinesterase inhibition in Alzheimer's disease: is specificity the answer?
Macdonald IR; Rockwood K; Martin E; Darvesh S
J Alzheimers Dis; 2014; 42(2):379-84. PubMed ID: 24898642
[TBL] [Abstract][Full Text] [Related]
18. Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease?
Martorana A; Esposito Z; Koch G
CNS Neurosci Ther; 2010 Aug; 16(4):235-45. PubMed ID: 20560995
[TBL] [Abstract][Full Text] [Related]
19. [Neurotransmitters in Alzheimer's disease].
Manzano-Palomo S; De la Morena-Vicente MA; Barquero MS
Rev Neurol; 2006 Mar 16-31; 42(6):350-3. PubMed ID: 16575771
[TBL] [Abstract][Full Text] [Related]
20. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
Pacheco G; Palacios-Esquivel R; Moss DE
J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
